Jamnagar

Medley was accredited as ISO - 9001 : 2000 company during the year 2003, by American Quality Assessors (AQA). Medley believes that quality is a continuous process and not an isolated stage in the process.
Medley's strength has also been it's product portfolio which has expanded in response to the market needs. As a strategic move towards success, the company has launched its cadiovascular, anti diabetic and neuropsychiatry products through its highly specialized VAZOKARE division.

Torrent Pharma owes its success in the domestic market to its thrust on frontline research, strategic marketing and world-class manufacturing. It is among the largest spenders on R&D and has set up one of the most advanced research centers in the country at an investment of Rs. 200 crores so far. It has discovered and patented the AGE (Advanced Glycosylation End Product) Breaker Compound which has potential to treat heart diseases and diabetes related vascular complications.